This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Meetings & Medical Communications

Biologics pushing forward parenteral drug delivery

Posted by on 30 March 2017
Share this article

biologics-parenteralOver 60% of the drugs currently being researched and in clinical development are biologics.  To have the desired effect in the human body, they need administered via parenteral delivery.   The prefilled syringe industry is expected to grow to $6.9 billion by 2018.  This method also allows for many safety benefits for the patient using them: ease of administration, improved safety, reduced risk of contamination, and accurate dosing.

Our partners at Drug Development and Delivery recently wrote an article looking at the development and discovery of the ways that companies are expanding their parenteral delivery options.  They featured the following companies having promise in the prefilled syringe arena with their products:

  • Battelle Medical Devices - Demonstrating usability
  • Baxter Biopharma Solutions - Sterile Manufacturing Assures Compliance
  • Catelent Pharma Solutions - Expanding PFS Offerings
  • Lyophilization Technology, INC. - Easing The Handling Of Lyophilized Product
  • Pfanstiehl, INC. - Using Quality Excipients For Parenteral Formulations
  • Unlife- Differentiating Injectable Drugs
  • Vetter - Services That Address A Compound's Requirements
  • West Pharmaceutical Services, INC.- Small User-Friendly Devices
  • Yukin Medical, LLC - Improving Medication Preperation For Injection
Read the full article to find out why these companies are making an impact in the space.
(Originally published on May 30, 2014)
Share this article